As CMS removes procedures from its Inpatient-Only (IPO) list, Allison Oakes, Trilliant’s chief research officer, recommends that hospitals establish a clear outpatient strategy to…
* Through the Lilly Employer Connect platform, itsmulti-dose weight-loss drug device Zepbound KwikPen will beavailable to network pharmacies at a discounted price of $449for…
The way the body responds to standing up can impact health in older age, surprising new research has found. The team discovered that about…
Deal allows MUSC to expand primary care capacity while PPCP, one of the largest care practices in the state, gains long-term stability.The Medical University…
A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1…
The move toward infusion centers as the preferred site of care is not a short-term response. It aligns with broader industry trends, including specialty…
GLP-1 receptor agonists may reduce the risk of developing and dying from substance use disorders, a study found.The study, led by researchers at St.…
Editor’s NoteThis article is the latest in the Health Affairs Forefront series, Provider Prices in the Commercial Sector, featuring analysis and discussion of physician,…
Pets are great companions — but can they also make us healthier? Writing for the New York Times, Dana Smith explains the research on…
ViVE has become one of those industry gatherings where real conversations happen. Leaders from across healthcare come together to showcase ideas and pressure-test them.…